A topical anti-infective
ZHAWOC6027 ist a novel drug candidate against skin infections. In order to use it successfully, various properties need to be optimised.
Description
ZHAWOC6027, a novel drug candidate against skin infections, requires an optimized CMC, formulation, appropriate dosing regimens, regulatory tox package and registration. To this end, the synthesis and formulation of the active ingredient are being optimized in terms of medicinal chemistry and regulatory work packages are being processed.
Key data
Projectlead
Project team
Dr. Dimanthi Pliatsika, Dr. Alessandra Tania Zizzari
Project partners
BACOBA AG; Fachhochschule Nordwestschweiz FHNW
Project status
completed, 05/2019 - 04/2021
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Innovationsprojekt / Projekt Nr. 34227.1 IP-LS
Project budget
2'074'501 CHF